KRAS inhibitor-7
Product Specifications
UNSPSC Description
KRAS inhibitor-7 is a potent KRAS G12C inhibitor, extracted from patent WO2017087528A1, compound B[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-inhibitor-7.html
Solubility
10 mM in DMSO
Smiles
C=CC(N1CCN(C2=C3C=C(Cl)[C@@]([C@@]4=C(F)C=CC=C4O)=C(F)C3=NC(N5CC(N(C)C)C5)=N2)CC1)=O
Molecular Weight
528.98
References & Citations
[1]Liansheng Li, et al. 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof. WO2017087528A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135865/KRAS-inhibitor-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135865/
Clinical Information
No Development Reported
CAS Number
2022986-68-9
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NUDT8, NT (NUDT8, Nucleoside diphosphate-linked moiety X motif 8, mitochondrial)